MISSISSAUGA, Ontario, Sept. 23, 2005 (PRIMEZONE) -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com), a leading penny stock / small-cap information site, provides an update on a previously spotlighted company Biophan Technologies, Inc. (OTCBB:BIPH).
Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and image compatible with the magnetic resonance imaging (MRI) environment. The Company develops technologies that enable implanted medical systems such as pacemakers, interventional surgical devices such as catheters and guidewires, and devices such as stents to be safely and effectively imaged under MRI. Biophan is developing these same technologies to provide new MRI contrast agents. Other applications include drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 144 U.S. patents, licenses, or applications.
Biophan recently announced a Letter of Intent with MYOTECH, LLC to acquire marketing rights to MYOTECH's breakthrough Ventricular Assist Device. The MYO-VAD(tm) is a novel cardiac assist device for supporting blood flow with unique, life-saving features. Biophan Technologies, Inc. has secured the exclusive marketing and distribution rights to the MYO-VAD(tm) from MYOTECH, LLC.
The MYO-VAD(tm) is the first in a family of products based upon Direct Mechanical Ventricular Actuation (DMVA) technology. It consists of a flexible polymer "cup" that can be installed around the heart in approximately 3 minutes. Incorporating a pneumatically activated liner, the MYO-VAD(tm) operates by compressing and expanding bi-directionally, providing the energy that allows the heart to restore the input and output of blood to normal, life-sustaining levels. A previous version of the technology has been installed in over 700 animals and helped to save human lives in emergency-use situations.
The complete updated BIPH profile can be viewed at: http://www.allpennystocks.com/apsc/us/stock_profiles/biph.htm
About AllPennyStocks.com Media Inc.:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and U.S. site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs weekly penny stocks to watch, has a weekly market write-up, provides company spotlights, runs a unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, Nasdaq and OTC BB, and much more information for the average investor.
Although the majority of AllPennyStocks.com reports are independent, it has received compensation for carrying the report on Biophan Technologies, Inc. (OTCBB:BIPH); the amount AllPennyStocks.com has been compensated is sixteen thousand free-trading shares and four thousand seven hundred dollars in January 2004 by Trilogy Capital Partners, thirty two thousand six hundred dollars by the company in April 2004, fifteen thousand seven hundred dollars by the company in August 2004, twenty thousand seven hundred dollars by the company in March 2005, seven thousand five hundred dollars by the company in April 2005 and fifteen thousand dollars by the company in September 2005 for its efforts in presenting the BIPH profile on its web site and distributing it to its database of subscribers as well as other services. This creates an inherent conflict of interest and readers are encouraged to view the full disclaimer at http://www.allpennystocks.com/apsc/us/stock_profiles/biph.htm.